Cargando…
Association of low-dosage systemic corticosteroid use with disease burden in asthma
There is an ongoing debate about the benefit–risk balance of systemic corticosteroids (SCS) in asthma treatment. We investigated the associations between SCS use and disease burden in a database cohort of asthmatics, categorized into SCS and non-SCS prescription at baseline and quartiles (Q) by cumu...
Autores principales: | Matsunaga, Kazuto, Adachi, Mitsuru, Nagase, Hiroyuki, Okoba, Tomoko, Hayashi, Nobuya, Tohda, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403577/ https://www.ncbi.nlm.nih.gov/pubmed/32753647 http://dx.doi.org/10.1038/s41533-020-00192-x |
Ejemplares similares
-
A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2017) -
The current state and provisions for elderly patients with asthma
por: Iwanaga, Takashi, et al.
Publicado: (2017) -
Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study
por: Koya, Toshiyuki, et al.
Publicado: (2023) -
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group()
por: Bleecker, Eugene R., et al.
Publicado: (2022) -
Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
por: Muraki, Masato, et al.
Publicado: (2017)